Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$112.00+6.96 (+6.63%)
Close on Nov 17, 2026Market cap $7.02BP/E –Yield –
Twist Bioscience pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Twist Bioscience
Twist Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?